Felipe Barreto Schuch1, Ioannis Dimitrios Morres2, Panteleimon Ekkekakis3, Simon Rosenbaum4, Brendon Stubbs5. 1. 1Post-Graduation Program of Medical Sciences: Psychiatry,Federal University of Rio Grande do Sul,Porto Alegre,Brazil. 2. 2Exercise Psychology and Quality of Life Laboratory,Department of Physical Education and Sport Science,University of Thessaly,Trikala,Greece. 3. 3Department of Kinesiology,Iowa States University,Ames,IA,USA. 4. 4School of Psychiatry,University of New South Wales,Sydney,Australia. 5. 6Physiotherapy Department,South London and Maudsley NHS Foundation Trust,Denmark Hill,London,UK.
Abstract
OBJECTIVE: Although considerable evidence supports the efficacy of exercise as an antidepressant treatment, critical reviews informing routine practice and future research directions are scarce. METHODS: We critically reviewed exercise studies for clinically depressed adults, focussing on the PICOS criteria referred to participants, interventions, comparisons, outcomes, and study designs. RESULTS: Most studies have not screened their samples for symptom heterogeneity. Also, they have employed heterogeneous exercise interventions and control groups that may lead to an underestimation of the benefits of exercise. In addition, pragmatic trials allowing scalable replication and implementation in routine practice are scarce. Future studies, can consider the research domain criteria as a diagnostic framework, and conduct moderator analyses to identify depressed subgroups with symptomatology and biopsychosocial characteristics associated with differential responses to exercise interventions. The search for biomarkers of the antidepressant responses to exercise should be prioritised. Further, non-physically active comparison groups should be used to minimise treatment cross-overs and thus the underestimation of the effects of exercise interventions. Finally, the use of outcome measures that maintain their validity at low and moderate levels of symptom severity and the development of trials with a pragmatic design are essential. CONCLUSION: The current evidence base is fraught with methodological considerations that need to be taken into account in order to increase further our understanding on the impact of exercise as medicine in depression. Future research should include moderator analyses, incorporate biomarker assays, use appropriate control and comparison groups, assess outcomes with psychometrically sensitive measures, and prioritise pragmatic trials towards transition to routine practice.
OBJECTIVE: Although considerable evidence supports the efficacy of exercise as an antidepressant treatment, critical reviews informing routine practice and future research directions are scarce. METHODS: We critically reviewed exercise studies for clinically depressed adults, focussing on the PICOS criteria referred to participants, interventions, comparisons, outcomes, and study designs. RESULTS: Most studies have not screened their samples for symptom heterogeneity. Also, they have employed heterogeneous exercise interventions and control groups that may lead to an underestimation of the benefits of exercise. In addition, pragmatic trials allowing scalable replication and implementation in routine practice are scarce. Future studies, can consider the research domain criteria as a diagnostic framework, and conduct moderator analyses to identify depressed subgroups with symptomatology and biopsychosocial characteristics associated with differential responses to exercise interventions. The search for biomarkers of the antidepressant responses to exercise should be prioritised. Further, non-physically active comparison groups should be used to minimise treatment cross-overs and thus the underestimation of the effects of exercise interventions. Finally, the use of outcome measures that maintain their validity at low and moderate levels of symptom severity and the development of trials with a pragmatic design are essential. CONCLUSION: The current evidence base is fraught with methodological considerations that need to be taken into account in order to increase further our understanding on the impact of exercise as medicine in depression. Future research should include moderator analyses, incorporate biomarker assays, use appropriate control and comparison groups, assess outcomes with psychometrically sensitive measures, and prioritise pragmatic trials towards transition to routine practice.
Authors: Lara F Carneiro; Maria P Mota; Felipe Schuch; Andrea Deslandes; José Vasconcelos-Raposo Journal: Braz J Psychiatry Date: 2017-08-30 Impact factor: 2.697
Authors: Leila Jahangard; Anahita Rahmani; Mohammad Haghighi; Mohammad Ahmadpanah; Dena Sadeghi Bahmani; Ali R Soltanian; Shahriar Shirzadi; Hafez Bajoghli; Markus Gerber; Edith Holsboer-Trachsler; Serge Brand Journal: Front Psychol Date: 2017-12-12
Authors: Daryl Wayne Niedermoser; Nadeem Kalak; Anna Kiyhankhadiv; Serge Brand; Corinna Walter; Nina Schweinfurth; Undine E Lang Journal: Front Psychiatry Date: 2020-03-17 Impact factor: 4.157
Authors: Lukas Nebiker; Eric Lichtenstein; Alice Minghetti; Lukas Zahner; Markus Gerber; Oliver Faude; Lars Donath Journal: Front Psychiatry Date: 2018-07-19 Impact factor: 4.157
Authors: Andreas Heissel; Anou Pietrek; Melanie Schwefel; Kahar Abula; Gregor Wilbertz; Stephan Heinzel; Michael Rapp Journal: BMJ Open Date: 2020-04-14 Impact factor: 2.692